Inactive Instrument

Press Releases Biostage Inc Nasdaq

Equities

US41690A1060

End-of-day quote Nasdaq Other stock markets
- ^USD	-

04-15	Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding	CI
03-28	Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Harvard Apparatus Regenerative Technology : Q1 - 2024 HBIO Quarterly Earnings Presentation	05-07	PU
Harvard Apparatus Regenerative Technology : March 19, 2024 - Investor Presentation	03-18	PU
Harvard Apparatus Regenerative Technology : Q4 - 2023 HBIO Quarterly Earnings Presentation	03-07	PU
Harvard Apparatus Regenerative Technology : Northland Capital Markets Institutional Investor Conference 2023	18/09/23	PU
Harvard Apparatus Regenerative Technology : Q2 - 2023 HBIO Quarterly Earnings Presentation	08/08/23	PU
Biostage Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	19/07/23	AQ
Purcell & Lefkowitz LLP Is Investigating Biostage, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors	15/06/23	PR
Biostage to Host Investor Call	13/06/23	PR
Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease	31/05/23	AQ
BIOSTAGE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	10/04/23	AQ
Biostage Appoints Ron Packard to Board of Directors	10/04/23	AQ
BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	06/04/23	AQ
Biostage Announces $6 Million Financing to Advance Clinical Trial	06/04/23	AQ
BIOSTAGE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	30/03/23	AQ
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	14/03/23	AQ
BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	07/03/23	AQ
Biostage Announces Chairman and CEO Transition	02/03/23	PR
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers (form 8-K)	26/01/23	AQ
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	12/01/23	AQ
Biostage Amends CEO Employment Agreement	12/01/23	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biostage Inc Nasdaq

Equities

US41690A1060

Press Releases

Filters